Difference between revisions of "DZI20-210-Case-1"
From MGH Learn Pathology
(Edited automatically from page DZI20-210.) |
(Automatic edit to upgrade to new templates) |
||
| Line 1: | Line 1: | ||
| − | {{ | + | {{ServiceRequestCase |
| − | | | + | |identifier=DZI20-210-Case-1 |
| − | | | + | |intent=order |
| − | | | + | |category=409073007 |
| − | | | + | |priority=routine |
| − | | | + | |orderDetail=case |
| − | | | + | |locationCode=learn |
| − | | | + | |basedOn=DZI20-210 |
| − | + | |code=faculty | |
| − | + | |supportingInfo=SKIN: LEFT upper back and arm: CD8+ cutaneous T cell lymphoma. | |
| − | | | ||
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%. | ||
| + | |reasonCode=70 yo with 3 week history of hemorrhagic tumors | ||
| + | |subject=public | ||
| + | |performer=Vn048 | ||
| + | |authoredOn=October 21, 2020 02:16:00 PM | ||
| + | |requester=Vn048 | ||
| + | |sequence=1 | ||
}} | }} | ||
| − | {{ | + | {{Media |
| − | | | + | |basedOn=DZI20-210-Case-1 |
| − | | | + | |type=image |
| − | | | + | |view=show |
| − | | | + | |partOf=DZI20-210 |
| − | + | |frames=1 | |
| + | |reasonCode=H&E | ||
| + | |identifier=DZI20-210-Case-1_1 | ||
| + | |createdDateTime=October 21, 2020 02:16:00 PM | ||
| + | |operator=Vn048 | ||
| + | |subject=Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ | ||
| + | |modality=mrxs | ||
}} | }} | ||
